Evidence map›Paper›PMID 33495415›Full record

ArticleAging2021

Screening of Alzheimer's disease by facial complexion using artificial intelligence.

Yumi Umeda-Kameyama, Masashi Kameyama, Tomoki Tanaka, Bo-Kyung Son, Taro Kojima, Makoto Fukasawa, Tomomichi Iizuka, Sumito Ogawa, Katsuya Iijima, Masahiro Akishita

Open access · greenAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Facial Expressions as a Nexus for Health Assessment.Bioengineering (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Reimagining Resilience in Aging: Leveraging AI/ML, Big Data Analytics, and Systems Innovation.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Facial aging, cognitive impairment, and dementia risk.Alzheimer's research & therapy · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Applications of artificial intelligence in dementia.Geriatrics & gerontology international · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yumi Umeda-KameyamaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masashi KameyamaDepartment of Diagnostic Radiology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
Tomoki TanakaInstitute of Gerontology, The University of Tokyo, Tokyo, Japan.
Bo-Kyung SonInstitute of Gerontology, The University of Tokyo, Tokyo, Japan.
Taro KojimaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Makoto FukasawaDepartment of Nuclear Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Tomomichi IizukaCenter for Dementia, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Japan.
Sumito OgawaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Katsuya IijimaInstitute of Gerontology, The University of Tokyo, Tokyo, Japan.
Masahiro AkishitaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The University of Tokyo · JPTokyo Metropolitan Institute of Gerontology · JPFukujuji Hospital · JPJapan Anti Tuberculosis Association · JPTokyo Metropolitan Geriatric Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the increasing incidence and high morbidity associated with dementia, a simple, non-invasive, and inexpensive method of screening for dementia is yet to be discovered. This study aimed to examine whether artificial intelligence (AI) could distinguish between the faces of people with cognitive impairment and those without dementia.121 patients with cognitive impairment and 117 cognitively sound participants were recruited for the study. 5 deep learning models with 2 optimizers were tested. The binary differentiation of dementia / non-dementia facial image was expressed as a "Face AI score". Xception with Adam was the model that showed the best performance. Overall sensitivity, specificity, and accuracy by the Xception AI system and AUC of the ROC curve were 87.31%, 94.57%, 92.56%, and 0.9717, respectively. Close and significant correlations were found between Face AI score and MMSE (

Indexed as

Artificial IntelligenceFaceAgedAged, 80 and overAlzheimer DiseaseDisease ProgressionFemaleHumansMaleMass ScreeningSensitivity and Specificityartificial intelligencedementiafacemachine learning

Identifiers

PMID33495415
PMCPMC7880359
OpenAlexW3121930650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.